Carlsbad, CA, United States of America

Michael Williams

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Radiance Therapeutics, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Williams - Innovator in Brachytherapy Systems

Introduction

Michael Williams is an accomplished inventor based in Carlsbad, CA (US). He has made significant contributions to the field of medical technology, particularly in the development of brachytherapy systems. His innovative approach has led to advancements that enhance the effectiveness of cancer treatment.

Latest Patents

Williams holds a patent for a "System for brachytherapy," which includes single-use brachytherapy systems designed for the application of beta radiation to target tissue. This system features a cap that allows for the insertion of a radionuclide brachytherapy source (RBS) and a handle that can be removed from the cap. Once the handle is disengaged, the system becomes unusable for its original purpose unless repaired, ensuring safety and efficacy in its application.

Career Highlights

Michael Williams is currently associated with Radiance Therapeutics, Inc., where he continues to innovate in the field of medical devices. His work focuses on creating solutions that improve patient outcomes in cancer treatment.

Collaborations

Williams collaborates with notable colleagues, including Laurence J. Marsteller and James A. Fazio. Their combined expertise contributes to the advancement of technologies in the medical field.

Conclusion

Michael Williams is a key figure in the development of innovative brachytherapy systems, demonstrating a commitment to improving cancer treatment through his inventions. His contributions are vital to the ongoing evolution of medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…